Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0005 EUR | -.--% | -.--% | -.--% |
15/04 | Canntab Therapeutics Limited announced that it expects to receive CAD 0.1 million in funding | CI |
2023 | Canntab Therapeutics Limited Provide an Update on Product Delivery | CI |
Business Summary
Sales per Business
CAD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Cannabinoids and Terpenes
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Sales per region
CAD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 20/16/20 | |
President | 56 | 20/16/20 | |
Chief Tech/Sci/R&D Officer | - | 15/20/15 | |
Barry Polisuk
BRD | Director/Board Member | 61 | 11/18/11 |
Frank Candido
IRC | Investor Relations Contact | 59 | 01/18/01 |
Eric Malinski
SAM | Sales & Marketing | - | 01/18/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
President | 56 | 20/16/20 | |
Barry Polisuk
BRD | Director/Board Member | 61 | 11/18/11 |
Vitor Fonseca
BRD | Director/Board Member | 71 | 11/18/11 |
Chief Executive Officer | 63 | 20/16/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 38,909,159 | 33,562,159 ( 86.26 %) | 0 | 86.26 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+45.15% | 633.96Cr | |
-14.00% | 460.84Cr | |
+9.54% | 339.05Cr | |
-8.99% | 328.64Cr | |
+50.03% | 201.64Cr | |
-6.97% | 173.12Cr | |
-0.31% | 166.99Cr | |
+50.00% | 163.02Cr | |
-10.61% | 159.09Cr |
- Stock Market
- Equities
- PILL Stock
- TBF1 Stock
- Company Canntab Therapeutics Limited